Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Thursday, February 19, 2015

Portugal: Hepatitis C treatment 100% subsidised

Innovative drug, Sofosbuvir, to treat hepatitis C is 100% subsidised in Portugal since Tuesday evening and will be given to all patients who need it.

Eurico Castro Alves was speaking at the end of a meeting with the administrators of all hospital that treat hepatitis C in Portugal, Infarmed and the secretary of state of health.

Alves said that an agreement had been signed with the laboratory that makes Sofosbuvir and the drug is now 100% state subsidised.

The Infarmed chairman said that all patients who needed the treatment would receive the drug and added that there are currently 602 receiving Sofosbuvir.

Read more...
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)